Sumitomo Pharma recorded core operating income of JPY19.9 billion, a significant year-over-year improvement of JPY116.2 billion. This was attributed to streamlined operations in North America, reduced ...
Shell’s (SHEL) recent share price weakness is a buying opportunity, Argus analyst Bill Selesky tells investors in a research note. As the ...
Manufacturing PMI in Germany increased to an 8-month high of 45 points in January from 42.50 points in December, exceeding ...
EIPI ETF has a mix of MLPs, oil & gas majors, and utilities, combined with active management. Read what makes EIPI is ...